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Macrophage C-type lectin (MCL) and macrophage inducible C-type lectin (Mincle) com-
prise part of an extensive repertoire of pattern recognition receptors with the ability to
sense damage-associated and pathogen-associated molecular patterns. In this review, we
cover the discovery and molecular characterization of these C-type lectin receptors, and
highlight recent advances in the understanding of their roles in orchestrating the response
of the immune system to bacterial and fungal infection, and damaged self. We also discuss
the identification and structure–activity relationships of activating ligands, particularly tre-
halose dimycolate and related mycobacterial glycolipids, which have significant potential in
the development of TH1/TH17 vaccination strategies.
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INTRODUCTION
Macrophage C-type lectin (MCL; Clec4d, ClecSf8) and
macrophage inducible C-type lectin (Mincle; Clec4e, ClecSf9)
are transmembrane germline-encoded pattern recognition recep-
tors (PRRs) that form part of the innate immune system. These
C-type lectin receptors (CLRs) recognize damage-associated mol-
ecular patterns (DAMPs) and enable immune sensing of damaged
self, and pathogen-associated molecular patterns (PAMPs) from a
growing list of bacteria and fungi (Figure 1) (1, 2). The PAMPs
notably include mycobacterial trehalose dimycolate (TDM, cord
factor), and appear to play a significant roles in the immune
response to certain bacterial and fungal infections. In the case
of Mincle, recognition of PAMPs is mediated through the car-
bohydrate binding part of the carbohydrate recognition domain
(CRD) in the extracellular region of the CLR, whereas recognition
of DAMPs occurs through a distinct region of the CRD (3). For
both CLRs, signal transduction occurs through the immunorecep-
tor tyrosine-based activation motif (ITAM)-containing adaptor
molecule Fc receptor γ-chain (FcRγ). Ligand binding to Mincle
leads to phosphorylation of the ITAM of FcRγ and recruitment
of spleen tyrosine kinase (Syk) (3). Syk recruitment by FcRγ leads
to nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-κB) activation through Card9–Bcl10–MALT1 signalosomes,
pivotal regulators that link innate and adaptive immune responses
(4). DNA transcription leads to the production of cytokines and
chemokines that shape the development of naïve T cells into effec-
tor T helper (TH) cell TH1 and TH17 subtypes (5). There is a
growing interest in the immunological roles of MCL and Mincle
for the development of defined synthetic adjuvants for TH1/TH17
vaccination, and due to the involvement of these CLRs in the
recognition of bacterial and fungal pathogens, and the response to
dysregulated cell death.
MCL AND MINCLE: C-TYPE LECTIN RECEPTORS
The genetic and molecular analysis of MCL and Mincle pre-
ceded the understanding of their function. MCL was originally
cloned as a mouse macrophage-restricted C-type lectin (6). Min-
cle was cloned as a transcriptional target of the nuclear factor
NF-IL-6, which binds the interleukin-1 (IL-1) responsive ele-
ment of the IL-6 gene (7). Mincle RNA was induced upon
exposure to inflammatory stimuli including lipopolysaccharide
(LPS), tumor necrosis factor-α (TNFα), IL-6, and interferon-γ
(IFNγ). Cloning/identification of the human and rat genes fol-
lowed shortly thereafter (8, 9). According to the HUGO Gene
Nomenclature Committee, the gene encoding MCL is CLEC4D
(formerly CLECSF8) and that encoding Mincle is CLEC4E (for-
merly CLECSF9). Both CLRs are located on mouse chromosome
6 and human chromosome 12, clustered with closely related CLRs
of the Dectin-2 family (Dectin-2, DCIR, DCAR, and BDCA-2)
within the telomeric region of the natural killer complex (10).
Sequence analyses predict type 2 transmembrane proteins with
an N-terminal cytoplasmic tail, a transmembrane region, a mem-
brane proximal stalk, followed by a single C-terminal C-type lectin
domain (11). The transmembrane region of Mincle contains a
positively charged arginine that mediates interaction with ITAM-
bearing adaptors; a direct interaction of Mincle with FcRγ was
obtained by immunoprecipitation of Mincle using an anti-FcRγ
antibody in transfected human embryonic kidney cells, with the
precipitation abolished upon substitution of arginine by leucine
(Figure 2A) (3). This interaction is critical for the ability of Min-
cle to signal as Mincle-dependent signaling is lost in the leucine
mutant (3).
Macrophage C-type lectin is an FcRγ coupled receptor (12) that
signals through Syk (13); however the nature of the adaptor pro-
tein interaction is unclear (Figure 2A). MCL does not contain an
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FIGURE 1 | Key events in the history of MCL and Mincle. This timeline depicts some of the critical discoveries that have shaped our understanding of the
function and roles of MCL and Mincle.
FIGURE 2 | Signaling through Mincle and MCL. (A) Mincle and MCL
pair with the signaling adaptor molecule Fc receptor γ-chain (FcRγ). With
Mincle this association is driven by the presence of a positively charged
arginine in the transmembrane region whereas the corresponding
residue is not present in MCL. Upon binding to DAMPs or fungal and
bacterial PAMPs, phosphorylation of the immunoreceptor tyrosine-based
activation motifs (ITAMs) of FcRγ recruits spleen tyrosine kinase (Syk)
and induces signaling through the Card9–Bcl10–MALT1 complex.
Transcription results in the formation of immunoregulatory cytokines and
chemokines. (B) Heterodimers of MCL and Mincle have the capacity to
sense trehalose dimycolate (TDM). In these complexes, Mincle
recognizes the carbohydrate headgroup while MCL recognizes the lipid
tail, and Mincle acts as a bridge to enable formation of a functional
MCL–Mincle–FcRγ complex.
arginine residue within the transmembrane domain that is typi-
cally required for association with FcRγ and so a direct interaction
with this adaptor seems unlikely. Immunoprecipitation of MCL in
a rat myeloid cell line led to co-precipitation with FcRγ (14) but
this could not be replicated in a transfected non-myeloid cell line,
indicating that additional cellular components are required for
this interaction (15). Co-transfection of non-myeloid cells with
MCL, Mincle, and FcRγ followed by immunoprecipitation gave
evidence for a covalently linked heterodimer of MCL and Min-
cle that associated with FcRγ, suggesting that Mincle acts as a
bridge for the interaction between MCL and FcRγ (Figure 2B)
(15, 16). Phagocytic internalization of anti-Mincle and anti-MCL
coated beads provided strong evidence for a functional com-
plex of MCL–Mincle–FcRγ on the cell surface. In primary rat
peritoneal macrophages, expression of Mincle and MCL is tightly
coupled, suggesting that Mincle–MCL heterodimers are formed.
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It was proposed that in Mincle–MCL heterodimers, TDM bind-
ing is mediated through carbohydrate binding to Mincle and lipid
binding to MCL, a model that explains the ability of MCL to rec-
ognize soluble TDM but not TDM associated with mycobacterial
cells.
In humans and rodents, Mincle is expressed on monocytes,
macrophages, neutrophils, dendritic cells (DCs), and some sub-
sets of B cells (3, 7, 17–19), and has been additionally detected on
T cells and concanavalin A blasts in rats (9). Mincle is inducible
on mouse macrophages upon activation of TLR4 (18), and is also
inducible on human B cells through activation of TLR9 (17). In
guinea pig, Mincle is expressed in the spleen, lymph nodes, and
peritoneal macrophages and is up-regulated upon stimulation by
zymosan and TDM (20).
Macrophage C-type lectin expression was first characterized as
macrophage-restricted in mice (6). Human MCL is expressed on
macrophages (synovial, peritoneal, and blood monocyte-derived)
and Langerhans cells (8), and on neutrophils, monocytes, and
immature and mature DCs (13). In rats, expression of MCL has
been detected on macrophages, neutrophils, DCs, B cells, and
T cells (9, 14). Upon treatment with various stimuli including
PAM3CSK4, TNF-α, and IFNγ, MCL expression is inducible on
monocytes and neutrophils (8, 13), but considerable variation
is found between studies. For example, using monocytes from
human donors, Arce et al. qualitatively demonstrated that IL-6,
TNF-α, IL-10, and IFNγ caused up-regulation of MCL expression,
whereas LPS caused down-regulation (8). In contrast, using simi-
lar protocols and cell lines, Graham et al. obtained different results
(13). LPS caused up-regulation; and TNF-α, IFNγ, IL-6, and IL-
10 did not change expression levels, although a less than twofold
change in expression levels was observed. Expression of MCL on
rat macrophages is inducible with IFNγ and pro-inflammatory
stimuli from Gram-negative bacteria (14).
Carbohydrate recognition by lectins is frequently associ-
ated with conserved glutamic acid–proline–asparagine (EPN) or
glutamine–proline–aspartate (QPD) motifs within the CRDs of
C-type lectins (see Box 1) (21). Mincle contains an EPN motif
within its CRD, leading to the suggestion of mannose/fucose/N-
acetylglucosamine/glucose specificity, which is commonly seen
for such motifs. While MCL contains a conserved Ca2+ bind-
ing site, it lacks a canonical EPN or QPD motif, instead
possessing an EPX motif in rat (X=K) and human (X=D),
whereas mouse possesses an ESN sequence. Insight into carbo-
hydrate recognition by Mincle and MCL was assessed for six
hexoses: mannose, fucose, N-acetylglucosamine, glucose, galac-
tose, and N-acetylgalactosamine (22). Relative affinities for Min-
cle were mannose ~ fucose> glucose>N-acetylglucosamine>
galactose ~ N-acetylgalactosamine. These relative affinities were
roughly paralleled by MCL: mannose ~ fucose> glucose ~ N-
acetylglucosamine> galactose ~ N-acetylgalactosamine, although
this CLR bound only very weakly to all hexoses examined. A screen
of a 326-member carbohydrate microarray for ligands for a sol-
uble MCL–Fc fusion protein failed to identify any carbohydrate
ligands for this receptor (13), suggesting that MCL may not in fact
be a carbohydrate binding lectin.
Functional studies of CLRs have been greatly accelerated
through the development of reporter cell lines. In the case of Min-
cle, a useful reporter is a T cell hybridoma that expresses Mincle
and FcRγ, as well as green fluorescent protein (GFP) under the
control of the transcription factor nuclear factor of activated T cells
(NFAT) to detect ITAM-mediated signals (3). An MCL reporter
strain in which LacZ β-galactosidase is expressed under the control
of NFAT in a T cell hybrid has been reported (15).
MINCLE IN THE DAMAGED CELL RESPONSE
Dead cells activate Mincle-expressing cells. The factor causing acti-
vation was identified to be spliceosome-associated protein 130
(SAP130) (3). SAP130 binds to Mincle in a Ca2+ independent
manner and mutation of the EPN motif of Mincle did not affect
binding. Conversely, a mutant in the region recognized by a block-
ing antibody, VEGQW, was not activated by dead cells, suggesting
that SAP130 binds to the CRD but at a distinct site to that of
carbohydrate binding. SAP130 derived from either living or dead
cells has a similar ability to activate through Mincle. As SAP130
is located in the nucleus in live cells, Mincle recognition of dead
cells must occur after translocation to the external milieu. SAP130
therefore acts as a DAMP, providing an alarm signal for dysreg-
ulated cell death. Gamma-ray irradiation causes cell death in the
thymus and induces neutrophil infiltration. Mincle RNA is up-
regulated after irradiation, but use of a Mincle-blocking antibody
suppressed neutrophil infiltration into the thymus after irradia-
tion. The observation that macrophage inflammatory protein 2
(MIP-2), a specific signal produced by thymic macrophages, was
inhibited by the Mincle-blocking antibody suggests that Mincle
Box 1 C-type lectins: structure and classification.
C-type lectins are a subclass of lectins that are distinguished by a requirement for Ca2+ for binding (21). Crystallographic studies reveal
that C-type lectins contain a compact globular structure that comprises the carbohydrate recognition domain (CRD). The CRD contains
conserved amino acid residue motifs, and which allows the prediction of new C-type lectins on the basis of sequence data. Somewhat
confusingly, it has since been found that many predicted C-type lectin CRDs do not bind either carbohydrates or Ca2+. C-type lectins can be
soluble or transmembrane proteins. An early classification of C-type lectins was introduced on the basis of (1) the identification of mannose-
or galactose-specific binding motifs [glutamic acid–proline–asparagine (EPN) or glutamine–proline–aspartate (QPD) motifs, respectively] in
well-characterized mannose- and galactose-specific lectins known at the time, and (2) conversion of the ligand specificity from mannose to
galactose by mutagenesis (23). Although based on compelling studies at the time, this further adds to the confusion as some predicted
mannose or galactose binding C-type lectins do not in fact bind to these carbohydrates. C-type lectins are classified into 17 groups; Mincle
and MCL fall into Group II of the CTL family and are typically grouped in with a subset of CTLRs termed the Dectin-2 cluster that contains
other PRRs including Dectin-2, DCIR, DCAR, and BDCA-2 (10).
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activation by ligands induces the production of inflammatory
cytokines and/or chemokines.
Ischemia results in dysregulated cell death and the exit of cellu-
lar components, suggesting the possible involvement of Mincle-
mediated inflammation. Mincle knockout mice show a better
outcome after stroke (24). Cerebral ischemia results in induc-
tion of Mincle expression in immune, neuronal, and endothelial
cells, which paralleled increases in SAP130 expression (25). Lev-
els of phosphorylated-Syk (p-Syk) were raised following ischemia
suggesting that Mincle activation leads to increased levels of p-
Syk. Application of the Syk inhibitor piceatannol reduced infarct
volume and swelling, suggesting that signaling through the Syk-
Card9–Bcl10–Malt1 axis is an important factor in the response to
ischemia.
IDENTIFICATION OF MYCOBACTERIAL GLYCOLIPIDS AS MCL
AND MINCLE ANTIGENS AND THEIR ROLE IN
MYCOBACTERIAL INFECTION
Research in the areas of mycobacterial immunogenicity and C-
type lectins began to merge with the report that TDM activates
macrophages and DCs via Syk–Card9–Bcl10–Malt1 signaling to
produce innate activation that was distinct from that produced
by Toll-like receptor ligands (4). Activation of antigen presenting
cells was independent of Dectin-1 but required the ITAM-bearing
signaling adaptor FcRγ, leading to the suggestion that a range
of C-type lectins, including Mincle, were possible TDM recep-
tors (4). Independently, Mincle had been shown to be associated
with FcRγ (3). Two contemporaneous reports identified Min-
cle as a TDM receptor. Using Mincle-expressing reporter cells,
Yamasaki and co-workers showed that while heat-killed mycobac-
teria could activate Mincle-expressing cells, delipidated cells could
not, and the activity was located within the lipid extract (26, 27).
Sub-fractionation of this extract identified TDM as the activating
species. Independently, Lang and co-workers mined a gene expres-
sion array database for genes expressed and up-regulated in bone
marrow macrophages treated with TDB (28). The candidate Min-
cle was expressed as an Fc fusion protein and was shown by ELISA
to bind to TDB and TDM in a dose-dependent manner. TDM is an
important glycolipid produced by all mycobacteria that possesses
potent immunostimulatory properties, in particular the ability to
cause granulomas. Using Mincle−/−mice, Mincle was shown to be
essential for the granulomatous response to TDM, providing com-
pelling evidence that Mincle is a major TDM receptor (26). While
initial reports demonstrated that TDM activates mouse Mincle,
a recent report using a reporter cell has shown that TDM also
activates human Mincle (29).
The discovery that MCL is a receptor for TDM arose from
the initial observation that MCL is expressed on neutrophils
and monocytes and triggers cellular activation through Syk (13).
The observation that resting macrophages barely express Min-
cle, yet addition of TDM drives Mincle expression, suggested
the existence of another TDM receptor (12). Innate immune
responses were impaired in MCL-deficient mice, including the
TDM-induced acquired immune response, experimental autoim-
mune encephalomyelitis (EAE) (12). Further, MCL was shown to
be required to drive Mincle expression in a Clec4e–GFP fusion
reporter mouse (12). Daws reported that MCL reporter strains
were not responsive to intact mycobacteria and argued that this
observation is consistent with MCL recognizing the lipid portion
of TDM, which is exposed in the purified antigen but embedded
in the bacterial cell wall in intact bacteria (15). Recent studies of
guinea pig homologs of Mincle (gpMincle) and MCL (gpMCL)
revealed that only gpMincle binds TDM and that gpMincle is con-
stitutively expressed (20). gpMCL lacks the hydrophobic region
proposed to be involved in TDM binding, although it does bind
FcRγ. This work suggested that of these two receptors, only
gpMincle is involved in guinea pig immune responses against
mycobacteria and that the functions of MCL and Mincle in recog-
nition of mycobacteria are not conserved between humans and
guinea pig.
The identification of Mincle and MCL as TDM receptors and
establishing that Mincle is required for the TDM-induced gran-
ulomatous response has resolved longstanding questions in the
field. However, the connection of Mincle and MCL to the anti-
mycobacterial response in the context of infection has been less
clearly answered (30). An early role for the cytosolic adaptor
caspase recruitment domain family, member 9 (Card9) in pul-
monary tuberculosis was demonstrated when Card9−/− mice
were shown to succumb rapidly to aerosol infection by Mycobac-
terium tuberculosis H37Rv (31). Comparison of bone marrow
derived macrophages of wild-type and Card9−/− mice when
infected with M. tuberculosis revealed a significant reduction in
the homozygous mutant of the pro-inflammatory cytokines, TNF,
IL-1β, and IL-6, and reduced IL-12 and CCL5, compared to
wild-type. Heat-killed Mycobacterium bovis, Mycobacterium smeg-
matis, and M. tuberculosis H37Rv all activated an NFAT-driven
GFP reporter strain that expresses Mincle and FcRγ, with acti-
vation ablated upon mutation of the Mincle CRD EPN motif
to QPD (26). The effect of Mincle deletion upon M. tuberculo-
sis infection has been studied in Mincle−/− mice. While in the
absence of Mincle, macrophages did not produce the reactive
nitrogen species NO2− upon TDM stimulation, Mincle-deficient
macrophages were responsive to M. tuberculosis infection, and co-
stimulation with IFNγ resulted in normal levels of granulocyte
colony-stimulating factor (G-CSF), TNF and NO2−. Mincle−/−
mice did not form granulomas upon stimulation with TDM,
the same mice forms granulomas that were indistinguishable
from wild-type upon infection with M. tuberculosis. Further-
more, while TDM resulted in induction of TH1 and TH17 cells,
Mincle−/− mice infected with M. tuberculosis developed normal
TH1 and TH17 immune responses, indicating that in the context
of M. tuberculosis infection, Mincle is not required for instructing
maturation of naïve T cells. This observation is consistent with
studies with Fonsecaea pedrosoi that suggests that while specific
signals are transmitted by Mincle during vaccination with puri-
fied TDM, PRR co-stimulation during infection leads to a cocktail
of cytokines and chemokines that shape T cell development (32)
(see Box 2).
MCL-deficient mice have defective immune responses to
mycobacterial infection. Induction of TNF and MIP-2 RNA was
impaired in bone marrow derived macrophages from MCL−/−
mice (12). Further, MCL−/− mice gave impaired IFNγ levels in
Mantoux test responses when stimulated with purified protein
derivative compared to wild-type.
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Box 2 The role of MCL and Mincle inT cell development.
Upon recognition of their cognate antigen, naïve CD4+ T cells (TH0 cells) can differentiate into novel effector CD4+ T cell lineages that can
regulate or assist active immune responses (Figure 3). The fate of the transforming TH0 cell is determined by the pattern of cytokines it
receives at the moment of antigen recognition by the T cell receptor. Activation of Mincle and MCL induces expression of interleukins-1
(IL-1) and IL-6 in antigen presenting cells (4, 19, 26, 33, 34), which flood the microenvironment of the transforming TH0 cell and shape the
development of TH1 and TH17 phenotypes in both humans and mice (12, 28). The TH17 lineage is defined by the production of IL-17, which
induces and mediates pro-inflammatory responses leading to the recruitment of monocytes and neutrophils, which can clear infections
(35).TH1 cells characteristically produce IFNγ, an activator of natural killer cells (which provide direct killing of pathogens) and macrophages
(leading to phagocytosis).
FIGURE 3 |T cell differentiation upon stimulation of Mincle/MCL.
Glycerol monomycolate (GroMM) has been identified as a
Mincle-activating lipid (29). Using NFAT–GFP reporter strains,
it was shown that human Mincle-expressing cells could be
activated by GroMM, although less potently than for TDM.
While mouse Mincle-expressing cells were not activated by
GroMM, transgenic mice expressing human Mincle gained the
ability to recognize GroMM, and injection of GroMM lipo-
somes into the skin of these mice resulted in infiltration of
macrophages and eosinophils. In primary human monocyte-
derived macrophages, GroMM produced TNFα in response to
GroMM that could be blocked by an anti-human Mincle anti-
body, demonstrating that this glycolipid is a ligand for human, but
not mouse Mincle.
STRUCTURE–ACTIVITY RELATIONSHIPS OF TREHALOSE AND
GLYCEROL-BASED ANTIGENS FOR MINCLE
Mincle is potently activated by TDM (Figure 4). Treatment of
TDM with trehalase, which apparently cleaves this molecule into
glucose monomycolate (GMM), abolished Mincle binding (26).
This result suggests that Mincle specifically recognizes the two
glucose residues within TDM and is particularly interesting as
GMM is a glycolipid produced upon infection by M. tuberculosis
and which itself is a potent antigen when presented to T cells by
CD1b (36). Cells are activated to similar degrees by the TDM ana-
log trehalose dibehenate, which suggests that complex mycolate
structures are not necessary for Mincle activation. Measurement
of the direct interaction of Mincle with TDM analogs is limited by
their poor solubility and so accurate data has only been obtained
with shorter acyl groups. For bovine Mincle, affinities of tre-
halose diesters generally increase with increasing chain length (37).
Trehalose monoesters are also effective ligands for human and
bovine Mincle with affinities increasing up to 6-O-lauryltrehalose
FIGURE 4 | Mycobacterial mycolic acid-based lipids and synthetic
analogs (TDB and GMB), structurally defined glycolipid ligands for
MCL and Mincle.
(C12) and 6-O-octanoyltrehalose, respectively (37, 38). Trehalose
itself is a weak ligand for Mincle, and methyl α-glucoside, rep-
resenting a monomer of trehalose, possesses 36-fold weaker
affinity for Mincle (37). The C22 and C26 trehalose monoesters
were able to activate mouse macrophages in a Mincle-dependent
manner (34).
Glycerol monomycolate is an antigenic ligand for human, but
not mouse Mincle (Figure 4) (29). Plate-bound GroMM is less
potent than TDM in an NFAT–GFP reporter cell assay. Glyc-
erol monobehenate (GMB) possesses similar activity to GroMM
toward human Mincle and gave only marginal responses for mouse
Mincle reporter cells.
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STRUCTURES OF CRDs OF MCL AND MINCLE
The classification of Mincle and MCL as CLRs leads to the
prediction that the CRD domain will conform to the typical
domains seen for this class of proteins. Two recent papers have
independently reported structures of Mincle and MCL C-type
lectin domains. Maenaka and co-workers reported the struc-
tures of human Mincle and MCL, recombinantly expressed in
Escherichia coli (38). While wild-type human Mincle failed to crys-
tallize, the I99K mutant (which matches the equivalent residue in
human MCL) provided diffracting crystals. Drickamer and co-
workers have reported the structure of bovine Mincle, expressed
using a similar approach and crystallized without the need for
mutagenesis (37).
The human MCL C-type lectin domain comprises a globular
fold containing two alpha helices around a beta-strand core, with
a single Ca2+ bound (Figure 5A) (38). The human and bovine
Mincle C-type lectin domains reveal largely identical folds, and
both contain two Ca2+ ions, with the bovine structure contain-
ing an additional Na+ ion (Figure 5B) (38). Structural insight
into carbohydrate recognition by Mincle was obtained through a
complex of bovine Mincle with trehalose (Figure 5C) (37). In this
complex, only one pyranose ring of trehalose binds to calcium
through O3 and O4 of glucose (Figure 5D). Insight into a possible
molecular basis for signal transduction was obtained through a
conformational change in a loop between Asn-170 and Asp-177
near the conserved Ca2+ upon biding of trehalose. Examination
of the surface of Mincle near the trehalose binding site identified
a hydrophobic channel lined with lipophilic amino acids that is
adjacent to the 6-OH of the Ca2+-bound glucose ring, which was
proposed to comprise a lipid binding channel (Figure 5E).
MCL AND MINCLE IN FUNGAL DISEASE
Effective protection of host from pathogenic fungi and clearance
of infection requires a coordinated immune response from both
TH1 and TH17 cells that restrict fungal cell growth and drive
phagocytic clearance (2, 5). The Syk–Card9–Bcl10–MALT1 sig-
naling axis leads to NF-κB activation, which drives the expression
of multiple cytokines including IL-1, IL-6, and IL-23 that facili-
tate TH17 cell differentiation, and IL-12, which is essential for TH1
differentiation (see Box 2).
Yamasaki and co-workers screened 50 species of pathogenic
fungi as Mincle activators using a NFAT–GFP reporter cell line
(39). Of these only Malassezia species, including Malassezia pachy-
dermatis, Malassezia dermatis, Malassezia japonica, Malassezia
nana, Malassezia slooffiae, Malassezia sympodialis, and Malassezia
furfur, induced strong NFAT–GFP activation. Interestingly, partic-
ularly given results from other laboratories, Candida albicans did
not result in NFAT–GFP expression. In normal skin, Malassezia
spp. are commensals, however in atopic/eczema and psoriasis,
these fungi can elicit inflammatory responses in skin lesions and
can cause diseases such as tinea versicolor, atopic dermatitis, and
lethal sepsis. Reporter cells with mutant Mincle mutated in the
FIGURE 5 | Structures of the C-type lectin domains of (A) human MCL
(PDB: 3whd); (B) human Mincle (PDB: 3wh3); (C) bovine Mincle
complex with trehalose (PDB: 4kzv); (D) interactions with Ca2+ at the
primary glucose binding site of bovine Mincle; and (E) putative
hydrophobic channel adjacent to the primary glucose binding site of
bovine Mincle complex with trehalose (the protein surface is colored
according to the underlying atoms: light green, nitrogen/oxygen; dark
green, carbon).
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CRD were not activated by Malassezia indicating that the likely
ligand is a carbohydrate, and as discussed below, subsequent work
led to the isolation of glycolipids including gentiobiosyl diacyl-
glycerides and a complex mannosyloxylstearyl mannitol glycolipid
(40). Co-culture of M. pachydermatis with wild-type murine bone
marrow macrophages resulted in production of MIP-2, TNFα,
keratinocyte-derived chemokine (CXCL1), and IL-10 cytokines,
which were reduced but not ablated in Mincle−/− macrophages.
When M. pachydermatis was injected into the peritoneal cavity,
wild-type mice produced IL-6 and TNF, which was reduced in the
Mincle−/−mutant, suggesting that Mincle is important in immune
responses to these fungi.
Chromoblastomycosis is a chronic skin infection caused by
fungi including F. pedrosoi. F. pedrosoi is recognized by Mincle,
resulting in production of high levels of IL-10 and low levels of
TNF and IFNγ (32). Under these conditions, F. pedrosoi establishes
a chronic infection which is unable to be cleared. Co-stimulation
of macrophages and DCs infected with F. pedrosoi with the TLR2
agonist PAM3CSK4, the TLR7 agonist Imiquimod, or the TLR4
agonist LPS gave robust levels of TNF, suggesting that this fungus
fails to cause co-stimulation of PRRs. Indeed, Mincle−/− bone
marrow DCs lacked the ability to be co-stimulated by LPS and F.
pedrosoi, and F. pedrosoi infected mice effectively cleared dissemi-
nated infections with this fungus when treated with a single dose
of LPS. As well, topical application of Imiquimod significantly
decreased fungal burden in skin after subcutaneous infection. To
gain further insight into the mechanisms IL-6 of inflammatory
responses, Wevers and co-workers studied stimulation of human
DCs with the related fungus Fonsecaea monophora, also a causative
agent of chromoblastomycosis (41, 42). F. monophora triggered
the maturation of DCs and production of IL-6, IL-1β, and IL-
23, but not IL-12p70. In this case, F. monophora is recognized by
both Dectin-1 and Mincle, and while activation through Dectin-
1 resulted in cytokine production, Mincle activation resulted in
suppression of IL-12p70 through suppression of IL-12p35 tran-
scription. This in turn was achieved by Mincle signals targeting
the proteasomal degradation of nuclear IRF1 via the ubiquitin E3
ligase Mdm2. Mdm2 activation and translocation was a result of
Mincle triggering of the signaling kinase PKB, which was not trig-
gered by Dectin-1 or TLR4. Overall, this process leads to impair-
ment of IL-12 and is important for shaping the development of
CD4+ T cells toward TH17 cells. This appears to be a general phe-
nomenon for Mincle activation by other fungi including Fonsecaea
compacta and Cladophialophora carrionii, and indeed by the TDM
mimic TDB. Naïve CD4+ T cells co-cultured with DCs primed
with the TLR4 agonist LPS differentiate to TH1 polarized cells,
however in the presence of F. pedrosoi and other fungi, these are
skewed to a TH2 response.
Mincle appears to play crucial roles in C. albicans infection.
Mincle-deficient mice are more susceptible to systemic candidiasis,
and production of TNF-α by macrophages was reduced in vivo and
in vitro (43). The soluble CRD of human and mouse Mincle was
found to bind whole C. albicans cells (44). However, a subsequent
screening study of different C. albicans strains did not activate
a Mincle-expressing NFAT–GFP reporter strain, leading to the
suggestion that strain-specific features are required for Mincle acti-
vation (39). The identity of the C. albicans ligands is not known.
A direct role for MCL in fungal disease is yet to be demon-
strated. No significant differences were observed in the ability of
MCL-deficient mice to resist infection with C. albicans (13).
IDENTIFICATION OF MINCLE ANTIGENS FROM FUNGI
Gentiobiosyl diacylglycerides from M. pachydermatis have been
identified as mouse Mincle ligands (Figure 6) (40). These gly-
colipids bear anteiso fatty acyl groups (anteiso-C15, C17, C19, or
C20) at the sn-1 and sn-2 positions of the glycerol. Four lipo-
forms were identified with the following substituent permuta-
tions (sn-1/sn-2): anteiso-C19/anteiso-C15, anteiso-C17/anteiso-
C15, anteiso-C20/anteiso-C15, and anteiso-C19/anteiso-C17. All
isomers activated Mincle to similar degrees, but were significantly
less potent than TDM. While these gentiobiosyl diacylglycerides
bear significant resemblance to the glycolipid membrane anchor
of lipoteichoic acid, it did not activate via Mincle.
Malassezia pachydermatis produces a complex mannosyloxyl-
stearyl mannitol glycolipid that is a potent activator via mouse
Mincle, with a potency approaching that of TDM (Figure 7) (40).
This glycolipid comprises β-linked mannose residues attached to
10-hydroxystearic acid and esterified onto an l-mannitol core.
CONCLUSION
T cell mediated immune responses induced by PRRs are important
in recognition of damaged self and pathogens. The identification
of DAMPs and PAMPs that activate Mincle has elevated the impor-
tance of this CLR, and the involvement of MCL as an auxiliary
CLR that forms heterodimers with Mincle provides the potential
for an expansion in the range of ligands recognized by Mincle.
MCL and Mincle appear to be an important part of a larger reper-
toire of PRRs and recent studies of the interplay of Mincle with
Dectin-1 and TLRs demonstrate the potential for modulation of
immune signals through PRR co-stimulation. The availability of
three dimensional X-ray structures of the CRDs of these recep-
tors has unveiled a molecular picture of ligand recognition that
may inform development of novel TH1/TH17 vaccines. However,
at this stage it is not clear how Mincle can recognize a diverse range
of structurally dissimilar antigens, or the structural changes that
lead to signal transduction and transcription. Further, it is likely
that additional pathogens that activate MCL and Mincle remain
to be identified as well as new ligands from existing pathogens
such as Klebsiella pneumonia (45) and F. pedrosoi that activate
through Mincle. It is noteworthy that the majority of studies with
MCL and Mincle has been performed on mice and it will require
additional work to translate these findings to the human system.
FIGURE 6 | Gentiobiosyl diacylglycerides from the fungus Malessezia
pachydermatis, ligands for mouse Mincle.
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FIGURE 7 | Mannosyloxylstearyl mannitol glycolipid from Malessezia pachydermatis, a ligand for mouse Mincle.
The species differences noted in the expression and functional
properties of MCL and Mincle, and the selective activation of
human, but not mouse Mincle by GroMM, suggest that the devel-
opment of humanized animal models and cell lines will be essential
for understanding the role of these CLRs in human health and
disease.
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